The World Market for Natural or Synthetic Hormones, Hormone Derivatives, and Other Steroids Used as Hormones: A 2024 Global Trade Perspective
This report was created for strategic planners, international executives, and import/export managers who are concerned with the market for natural or synthetic hormones, hormone derivatives, and other steroids used as hormones excluding medicaments. With the globalization of this market, managers can no longer be contented with a local view. Nor can managers be contented with out-of-date statistics that appear several years after the fact. Professor Philip M. Parker, the Chair Professor of Management Science at INSEAD, has developed a methodology, based on macroeconomic and trade models, to estimate the market for natural or synthetic hormones, hormone derivatives, and other steroids used as hormones excluding medicaments for those countries serving the world market via exports or supplying from various countries via imports. He does so for the current year based on a variety of key historical indicators and econometric models.
"Natural or synthetic hormones, hormone derivatives, and other steroids used as hormones excluding medicaments" as a category is defined in this report following the definition given by the United Nations Statistics Division Classification Registry using the Standard International Trade Classification, Revision 3 (SITC, Rev. 3). The SITC code that defines "natural or synthetic hormones, hormone derivatives, and other steroids used as hormones excluding medicaments" is 5415.
1 METHODOLOGY
1.1 OUR APPROACH
2 THE WORLD MARKET
2.1 EXPORTS
2.1.1 THE WORLD MARKET: NATURAL OR SYNTHETIC HORMONES, HORMONE DERIVATIVES, AND OTHER STEROIDS USED AS HORMONES EXCLUDING MEDICAMENTS EXPORT SUPPLIES IN 2024
2.2 IMPORTS
2.2.1 THE WORLD MARKET: IMPORTED NATURAL OR SYNTHETIC HORMONES, HORMONE DERIVATIVES, AND OTHER STEROIDS USED AS HORMONES EXCLUDING MEDICAMENTS IN 2024
3 EXPORTS
3.1 AFRICA: EXPORT SUPPLIES OF NATURAL OR SYNTHETIC HORMONES, HORMONE DERIVATIVES, AND OTHER STEROIDS USED AS HORMONES EXCLUDING MEDICAMENTS IN 2024
3.1.1 EXECUTIVE SUMMARY
3.1.2 CAMEROON
3.1.3 ESWATINI
3.1.4 SOUTH AFRICA
3.2 ASIA: EXPORT SUPPLIES OF NATURAL OR SYNTHETIC HORMONES, HORMONE DERIVATIVES, AND OTHER STEROIDS USED AS HORMONES EXCLUDING MEDICAMENTS IN 2024
3.2.1 EXECUTIVE SUMMARY
3.2.2 CHINA
3.2.3 HONG KONG
3.2.4 INDIA
3.2.5 INDONESIA
3.2.6 JAPAN
3.2.7 MALAYSIA
3.2.8 SINGAPORE
3.2.9 SOUTH KOREA
3.2.10 TAIWAN
3.2.11 THAILAND
3.2.12 THE PHILIPPINES
3.3 EUROPE: EXPORT SUPPLIES OF NATURAL OR SYNTHETIC HORMONES, HORMONE DERIVATIVES, AND OTHER STEROIDS USED AS HORMONES EXCLUDING MEDICAMENTS IN 2024
3.3.1 EXECUTIVE SUMMARY
3.3.2 AUSTRIA
3.3.3 BELGIUM
3.3.4 BULGARIA
3.3.5 CROATIA
3.3.6 CYPRUS
3.3.7 DENMARK
3.3.8 FINLAND
3.3.9 FRANCE
3.3.10 GEORGIA
3.3.11 GERMANY
3.3.12 GREECE
3.3.13 HUNGARY
3.3.14 IRELAND
3.3.15 ITALY
3.3.16 LATVIA
3.3.17 LITHUANIA
3.3.18 LUXEMBOURG
3.3.19 MALTA
3.3.20 NORWAY
3.3.21 POLAND
3.3.22 PORTUGAL
3.3.23 ROMANIA
3.3.24 RUSSIA
3.3.25 SPAIN
3.3.26 SWEDEN
3.3.27 SWITZERLAND
3.3.28 THE CZECH REPUBLIC
3.3.29 THE NETHERLANDS
3.3.30 THE UNITED KINGDOM
3.4 LATIN AMERICA: EXPORT SUPPLIES OF NATURAL OR SYNTHETIC HORMONES, HORMONE DERIVATIVES, AND OTHER STEROIDS USED AS HORMONES EXCLUDING MEDICAMENTS IN 2024
3.4.1 EXECUTIVE SUMMARY
3.4.2 ARGENTINA
3.4.3 BRAZIL
3.4.4 COLOMBIA
3.4.5 COSTA RICA
3.4.6 EL SALVADOR
3.4.7 MEXICO
3.4.8 PANAMA
3.4.9 PARAGUAY
3.4.10 URUGUAY
3.5 NORTH AMERICA & THE CARIBBEAN: EXPORT SUPPLIES OF NATURAL OR SYNTHETIC HORMONES, HORMONE DERIVATIVES, AND OTHER STEROIDS USED AS HORMONES EXCLUDING MEDICAMENTS IN 2024
3.5.1 EXECUTIVE SUMMARY
3.5.2 BERMUDA
3.5.3 CANADA
3.5.4 CUBA
3.5.5 THE UNITED STATES
3.6 OCEANIA: EXPORT SUPPLIES OF NATURAL OR SYNTHETIC HORMONES, HORMONE DERIVATIVES, AND OTHER STEROIDS USED AS HORMONES EXCLUDING MEDICAMENTS IN 2024
3.6.1 EXECUTIVE SUMMARY
3.6.2 AUSTRALIA
3.6.3 NEW ZEALAND
3.7 THE MIDDLE EAST: EXPORT SUPPLIES OF NATURAL OR SYNTHETIC HORMONES, HORMONE DERIVATIVES, AND OTHER STEROIDS USED AS HORMONES EXCLUDING MEDICAMENTS IN 2024
3.7.1 EXECUTIVE SUMMARY
3.7.2 IRAN
3.7.3 ISRAEL
3.7.4 PAKISTAN
3.7.5 SAUDI ARABIA
3.7.6 THE UNITED ARAB EMIRATES
3.7.7 TURKEY
4 IMPORTS
4.1 AFRICA: NATURAL OR SYNTHETIC HORMONES, HORMONE DERIVATIVES, AND OTHER STEROIDS USED AS HORMONES EXCLUDING MEDICAMENTS IMPORTS IN 2024
4.1.1 EXECUTIVE SUMMARY
4.1.2 ALGERIA
4.1.3 EGYPT
4.1.4 ETHIOPIA
4.1.5 MOROCCO
4.1.6 NAMIBIA
4.1.7 NIGERIA
4.1.8 SOUTH AFRICA
4.1.9 UGANDA
4.1.10 ZIMBABWE
4.2 ASIA: NATURAL OR SYNTHETIC HORMONES, HORMONE DERIVATIVES, AND OTHER STEROIDS USED AS HORMONES EXCLUDING MEDICAMENTS IMPORTS IN 2024
4.2.1 EXECUTIVE SUMMARY
4.2.2 BRUNEI
4.2.3 CHINA
4.2.4 HONG KONG
4.2.5 INDIA
4.2.6 INDONESIA
4.2.7 JAPAN
4.2.8 MALAYSIA
4.2.9 NEPAL
4.2.10 SINGAPORE
4.2.11 SOUTH KOREA
4.2.12 SRI LANKA
4.2.13 TAIWAN
4.2.14 THAILAND
4.2.15 THE PHILIPPINES
4.2.16 VIETNAM
4.3 EUROPE: NATURAL OR SYNTHETIC HORMONES, HORMONE DERIVATIVES, AND OTHER STEROIDS USED AS HORMONES EXCLUDING MEDICAMENTS IMPORTS IN 2024
4.3.1 EXECUTIVE SUMMARY
4.3.2 ANDORRA
4.3.3 AUSTRIA
4.3.4 BELARUS
4.3.5 BELGIUM
4.3.6 BOSNIA AND HERZEGOVINA
4.3.7 BULGARIA
4.3.8 CROATIA
4.3.9 CYPRUS
4.3.10 DENMARK
4.3.11 ESTONIA
4.3.12 FINLAND
4.3.13 FRANCE
4.3.14 GEORGIA
4.3.15 GERMANY
4.3.16 GREECE
4.3.17 HUNGARY
4.3.18 IRELAND
4.3.19 ITALY
4.3.20 KAZAKHSTAN
4.3.21 LATVIA
4.3.22 LITHUANIA
4.3.23 LUXEMBOURG
4.3.24 MALTA
4.3.25 MOLDOVA
4.3.26 NORWAY
4.3.27 POLAND
4.3.28 PORTUGAL
4.3.29 ROMANIA
4.3.30 RUSSIA
4.3.31 SLOVAKIA
4.3.32 SLOVENIA
4.3.33 SPAIN
4.3.34 SWEDEN
4.3.35 SWITZERLAND
4.3.36 THE CZECH REPUBLIC
4.3.37 THE NETHERLANDS
4.3.38 THE UNITED KINGDOM
4.3.39 UKRAINE
4.4 LATIN AMERICA: NATURAL OR SYNTHETIC HORMONES, HORMONE DERIVATIVES, AND OTHER STEROIDS USED AS HORMONES EXCLUDING MEDICAMENTS IMPORTS IN 2024
4.4.1 EXECUTIVE SUMMARY
4.4.2 ARGENTINA
4.4.3 BELIZE
4.4.4 BOLIVIA
4.4.5 BRAZIL
4.4.6 CHILE
4.4.7 COLOMBIA
4.4.8 ECUADOR
4.4.9 EL SALVADOR
4.4.10 GUATEMALA
4.4.11 HONDURAS
4.4.12 MEXICO
4.4.13 NICARAGUA
4.4.14 PARAGUAY
4.4.15 PERU
4.4.16 SURINAME
4.4.17 URUGUAY
4.5 NORTH AMERICA & THE CARIBBEAN: NATURAL OR SYNTHETIC HORMONES, HORMONE DERIVATIVES, AND OTHER STEROIDS USED AS HORMONES EXCLUDING MEDICAMENTS IMPORTS IN 2024
4.5.1 EXECUTIVE SUMMARY
4.5.2 CANADA
4.5.3 THE DOMINICAN REPUBLIC
4.5.4 THE UNITED STATES
4.6 OCEANIA: NATURAL OR SYNTHETIC HORMONES, HORMONE DERIVATIVES, AND OTHER STEROIDS USED AS HORMONES EXCLUDING MEDICAMENTS IMPORTS IN 2024
4.6.1 EXECUTIVE SUMMARY
4.6.2 AUSTRALIA
4.6.3 NEW ZEALAND
4.7 THE MIDDLE EAST: NATURAL OR SYNTHETIC HORMONES, HORMONE DERIVATIVES, AND OTHER STEROIDS USED AS HORMONES EXCLUDING MEDICAMENTS IMPORTS IN 2024
4.7.1 EXECUTIVE SUMMARY
4.7.2 BAHRAIN
4.7.3 ISRAEL
4.7.4 JORDAN
4.7.5 KUWAIT
4.7.6 LEBANON
4.7.7 OMAN
4.7.8 PAKISTAN
4.7.9 QATAR
4.7.10 TURKEY
4.7.11 YEMEN
5 DISCLAIMERS, WARRANTIES, AND USER AGREEMENT PROVISIONS
5.1 DISCLAIMERS & SAFE HARBOR
5.2 ICON GROUP INTERNATIONAL, INC. USER AGREEMENT PROVISIONS